1) Han F, Zhang J, Guo Q, et al:Successful treatment of toxic epidermal necrolysis using plasmapheresis:A prospective observational study. J Crit Care 2017;42:65-8 2) Furubacke A, Berlin G, Anderson C, Sjöberg F:Lack of significant treatment effect of plasma exchange in the treatment of drug-induced toxic epidermal necrolysis? Intensive Care Med 1999;25:1307-10 3) Koštál M, Bláha M, Lánská M, et al:Beneficial effect of plasma exchange in the treatment of toxic epidermal necrolysis:a series of four cases. J Clin Apher 2012;27:215-20 4) Zimmermann S, Sekula P, Venhoff M, et al:Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis:A systematic review and meta-analysis. JAMA Dermatol 2017;153:514-22 5) Yamane Y, Matsukura S, Watanabe Y, et al:Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients―Treatment and outcome. Allergol Int 2016;65:74-81 6) Yamada H, Takamori K:Status of plasmapheresis for the treatment of toxic epidermal necrolysis in Japan. Ther Apher Dial 2008;12:355-9
